Great result, slightly disappointed by the market reaction to date. Big margin expansion, growing net profit 37%, forward PE of 10, share price should be much higher.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025